{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T02:00:06Z","timestamp":1789524006781,"version":"build-2803163510"},"reference-count":17,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Presse M\u00e9dicale"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.lpm.2016.06.009","type":"journal-article","created":{"date-parts":[[2016,9,10]],"date-time":"2016-09-10T00:52:32Z","timestamp":1473468752000},"page":"871-876","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Bilan \u00e9tiologique de l\u2019HTA\u00a0: dosages hormonaux toujours avant imagerie\u00a0?"],"prefix":"10.1016","volume":"45","author":[{"given":"Bernard","family":"Chamontin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florent","family":"Seguro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Touront","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9atrice","family":"Bouhanick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.lpm.2016.06.009_bib0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/fcp.12044","article-title":"Management of hypertension in adults: the 2013 French Society of Hypertension guidelines","volume":"28","author":"Blacher","year":"2014","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.lpm.2016.06.009_bib0095","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1097\/HJH.0b013e328353634e","article-title":"Clinical differences between resistant hypertensives and patients treated and controlled with three or less drugs","volume":"30","author":"de la Sierra","year":"2012","journal-title":"J Hypertens"},{"key":"10.1016\/j.lpm.2016.06.009_bib0100","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1161\/CIRCULATIONAHA.111.030189","article-title":"Uncontrolled and apparent treatment resistant hypertension in the United States, 1988 to 2008","volume":"124","author":"Egan","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.lpm.2016.06.009_bib0105","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/j.lpm.2014.07.016","article-title":"Management of resistant hypertension. Expert consensus statement from the French Society of Hypertension, an affiliate of the French Society of Cardiology","volume":"43","author":"Denolle","year":"2014","journal-title":"Presse Med"},{"key":"10.1016\/j.lpm.2016.06.009_bib0110","doi-asserted-by":"crossref","DOI":"10.1210\/jc.2015-4061","article-title":"The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline","author":"Funder","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.lpm.2016.06.009_bib0115","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ancard.2012.06.001","article-title":"An abdominal CT scan in first-line is an efficient investigation of uncontrolled hypertensives suspected to have an adrenal cause","volume":"61","author":"Rosenbaum","year":"2012","journal-title":"Ann Cardiol Angeiol"},{"key":"10.1016\/j.lpm.2016.06.009_bib0120","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1097\/HJH.0000000000000213","article-title":"European consensus on the diagnosis and management of fibromuscular dysplasia. Hypertension and the kidney","volume":"32","author":"Persu","year":"2014","journal-title":"J Hypertens"},{"key":"10.1016\/j.lpm.2016.06.009_bib0125","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1161\/HYPERTENSIONAHA.113.01060","article-title":"Cardiovascular complications associated with primary aldosteronism: a controlled cross-sectional study","volume":"62","author":"Savard","year":"2013","journal-title":"Hypertension"},{"key":"10.1016\/j.lpm.2016.06.009_bib0130","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S2213-8587(13)70211-0","article-title":"Cardiovascular events and mortality in patients with adrenal incidentalomas that are either non-secreting or associated with intermediate phenotype or subclinical Cushing's syndrome: a 15-year retrospective study","volume":"2","author":"Di Dalmazi","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"10.1016\/j.lpm.2016.06.009_bib0135","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1161\/HYPERTENSIONAHA.109.139832","article-title":"Within-patient reproducibility of the aldosterone: renin ratio in primary aldosteronism","volume":"55","author":"Rossi","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.lpm.2016.06.009_bib0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.ando.2016.02.003","article-title":"French SFE\/SFHTA primary aldosteronism consensus, part 2: first diagnostic steps","author":"Douillard","year":"2016","journal-title":"Ann Endocrinol (Paris)"},{"key":"10.1016\/j.lpm.2016.06.009_bib0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.ando.2016.05.001","article-title":"SFE\/SFHTA\/AFCE primary aldoteronism consensus: Introduction and handbook","author":"Amar","year":"2016","journal-title":"Ann Endocrinol (Paris)"},{"key":"10.1016\/j.lpm.2016.06.009_bib0150","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1530\/EJE-10-1147","article-title":"AME position statement on adrenal incidentaloma","volume":"164","author":"Terzolo","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.lpm.2016.06.009_bib0155","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1210\/jc.2014-1498","article-title":"Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline","volume":"99","author":"Lenders","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.lpm.2016.06.009_bib0160","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0140-6736(15)00257-3","article-title":"Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial","volume":"386","author":"Williams","year":"2015","journal-title":"Lancet"},{"issue":"17","key":"10.1016\/j.lpm.2016.06.009_bib0165","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1001\/jama.2010.1563","article-title":"Biochemical misdiagnosis of pheochromocytoma in patients treated with sulfasalazine","volume":"304","author":"Bouhanick","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.lpm.2016.06.009_bib0085","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1161\/HYPERTENSIONAHA.111.173948","article-title":"Primary hyperparathyroidism with concurrent primary aldosteronism","volume":"58","author":"Maniero","year":"2011","journal-title":"Hypertension"}],"container-title":["La Presse M\u00e9dicale"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498216301543?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498216301543?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,8]],"date-time":"2018-09-08T15:21:18Z","timestamp":1536420078000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0755498216301543"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":17,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S0755498216301543"],"URL":"https:\/\/doi.org\/10.1016\/j.lpm.2016.06.009","relation":{},"ISSN":["0755-4982"],"issn-type":[{"value":"0755-4982","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bilan \u00e9tiologique de l\u2019HTA\u00a0: dosages hormonaux toujours avant imagerie\u00a0?","name":"articletitle","label":"Article Title"},{"value":"La Presse M\u00e9dicale","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lpm.2016.06.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}